copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Avrion Tx Avrion Therapeutics precision gene therapies for neurodegeneration including motor neuron disease ALS
Science - Avrion Tx Avrion Therapeutics targets neurological disorders using precision gene therapy to enable long-term therapeutic solutions Avrion has developed a first-in-class precision gene therapy platform to selectively target discrete cells in the brain
About Us - Avrion Tx Avrion Therapeutics was founded in 2020 based on 10+ years of research from the Brain Mind Institute and Bertarelli Foundation Gene Therapy Platform at EPFL - the Swiss Federal Institute of Technology Lausanne led by the groups of Dr Bernard Schneider and Prof Brian McCabe
BOARD - Avrion Tx He co-founded Avrion Therapeutics in 2020, where he led as CEO until 2022 Prior to this, he held the position of COO at Cellestia Biotech from 2017 to 2020 Notably, Maximilien dedicated a decade to Debiopharm International SA as Associate Director, overseeing the Early Projects team
Contact - Avrion Tx Avrion Therapeutics precision gene therapies for neurodegeneration including motor neuron disease ALS
Management - Avrion Tx Avrion Therapeutics precision gene therapies for neurodegeneration including motor neuron disease ALS
advisory - avriontx. com Avrion Therapeutics precision gene therapies for neurodegeneration including motor neuron disease ALS
Gene therapy to treat amyotrophic lateral sclerosis Gene therapy to treat amyotrophic lateral sclerosis e therapy to address amyotrophic lateral sclerosis That is the ambitious project being conducted by Avrion Therapeutics AG and the Laboratory for Neural Ge etics and Disease at EPFL, supported by Innosuisse The work could lead to the d aralysis and death of patients with
Partners - avriontx. com Avrion Therapeutics precision gene therapies for neurodegeneration including motor neuron disease ALS
Strong Swiss delegation at Bio Europe rion Therapeutics: precision gene therapies for neurodegenerative diseases Avrion's first clinical candidate g Oculis: develops novel topical treatments (eye drops) for ophthalmic diseases for both back- and front-of-the-eye